MEOX2 regulates nuclear factor-B activity in vascular endothelial cells through interactions with p65 and IB

Yun Chen, Arnold B. Rabson, David H. Gorski

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Aims Tumours secrete proangiogenic factors to induce the ingrowth of blood vessels, the end targets of which are vascular endothelial cells (ECs). The MEOX2 homeoprotein inhibits nuclear factor-κB (NF-κB) signalling and EC activation in response to serum and proangiogenic factors. We hypothesize that MEOX2 interacts with components of this pathway in vascular ECs to modulate NF-κB activity and EC activation and that these interactions depend upon specific domains within the MEOX2 protein. Methods and results To test our hypothesis, we transduced ECs with MEOX2 expression constructs. MEOX2 protein localized to the nuclear fraction, as did IκBβ and p65. By co-immunoprecipitation, MEOX2 bound to both p65 and IκBβ. Immunofluorescence demonstrated that MEOX2 colocalizes in the nucleus with both p65 and IκBβ and that this colocalization requires the MEOX2 homeodomain and N-terminal domain. Finally, promoter assays revealed that MEOX2 expression has a biphasic effect on NF-κB-dependent promoters. At low levels, MEOX2 stimulates NF-κB activity, whereas at high levels, it represses, effects that also depend upon the homeodomain and the N-terminal domain. Conclusion Our results represent the first report of an interaction between a homeobox protein and IκBβ and suggest that MEOX2 modulates the activity of the RelA complex through direct interaction with its components. These observations implicate MEOX2 as a potentially important regulatory gene inhibiting not only the angiogenic response of ECs to proangiogenic factors, but also their response to chronic inflammatory stimulation that normally activates NF-κB, suggesting MEOX2 as a possible molecular target for the therapy of angiogenesis-dependent diseases such as cancer.

Original languageEnglish (US)
Pages (from-to)723-731
Number of pages9
JournalCardiovascular Research
Volume87
Issue number4
DOIs
StatePublished - Sep 1 2010
Externally publishedYes

Fingerprint

Cell Communication
Endothelial Cells
Homeodomain Proteins
Regulator Genes
Immunoprecipitation
Fluorescent Antibody Technique
Blood Vessels
Neoplasms
Proteins
Serum

Keywords

  • Angiogenesis
  • Homeodomain protein
  • Nuclear factor-κB
  • Transcriptional regulation
  • Vascular endothelial cell

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)
  • Physiology

Cite this

MEOX2 regulates nuclear factor-B activity in vascular endothelial cells through interactions with p65 and IB. / Chen, Yun; Rabson, Arnold B.; Gorski, David H.

In: Cardiovascular Research, Vol. 87, No. 4, 01.09.2010, p. 723-731.

Research output: Contribution to journalArticle

@article{33cd3ccf6b9b4511862e20bdbdacab0a,
title = "MEOX2 regulates nuclear factor-B activity in vascular endothelial cells through interactions with p65 and IB",
abstract = "Aims Tumours secrete proangiogenic factors to induce the ingrowth of blood vessels, the end targets of which are vascular endothelial cells (ECs). The MEOX2 homeoprotein inhibits nuclear factor-κB (NF-κB) signalling and EC activation in response to serum and proangiogenic factors. We hypothesize that MEOX2 interacts with components of this pathway in vascular ECs to modulate NF-κB activity and EC activation and that these interactions depend upon specific domains within the MEOX2 protein. Methods and results To test our hypothesis, we transduced ECs with MEOX2 expression constructs. MEOX2 protein localized to the nuclear fraction, as did IκBβ and p65. By co-immunoprecipitation, MEOX2 bound to both p65 and IκBβ. Immunofluorescence demonstrated that MEOX2 colocalizes in the nucleus with both p65 and IκBβ and that this colocalization requires the MEOX2 homeodomain and N-terminal domain. Finally, promoter assays revealed that MEOX2 expression has a biphasic effect on NF-κB-dependent promoters. At low levels, MEOX2 stimulates NF-κB activity, whereas at high levels, it represses, effects that also depend upon the homeodomain and the N-terminal domain. Conclusion Our results represent the first report of an interaction between a homeobox protein and IκBβ and suggest that MEOX2 modulates the activity of the RelA complex through direct interaction with its components. These observations implicate MEOX2 as a potentially important regulatory gene inhibiting not only the angiogenic response of ECs to proangiogenic factors, but also their response to chronic inflammatory stimulation that normally activates NF-κB, suggesting MEOX2 as a possible molecular target for the therapy of angiogenesis-dependent diseases such as cancer.",
keywords = "Angiogenesis, Homeodomain protein, Nuclear factor-κB, Transcriptional regulation, Vascular endothelial cell",
author = "Yun Chen and Rabson, {Arnold B.} and Gorski, {David H.}",
year = "2010",
month = "9",
day = "1",
doi = "10.1093/cvr/cvq117",
language = "English (US)",
volume = "87",
pages = "723--731",
journal = "Cardiovascular Research",
issn = "0008-6363",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - MEOX2 regulates nuclear factor-B activity in vascular endothelial cells through interactions with p65 and IB

AU - Chen, Yun

AU - Rabson, Arnold B.

AU - Gorski, David H.

PY - 2010/9/1

Y1 - 2010/9/1

N2 - Aims Tumours secrete proangiogenic factors to induce the ingrowth of blood vessels, the end targets of which are vascular endothelial cells (ECs). The MEOX2 homeoprotein inhibits nuclear factor-κB (NF-κB) signalling and EC activation in response to serum and proangiogenic factors. We hypothesize that MEOX2 interacts with components of this pathway in vascular ECs to modulate NF-κB activity and EC activation and that these interactions depend upon specific domains within the MEOX2 protein. Methods and results To test our hypothesis, we transduced ECs with MEOX2 expression constructs. MEOX2 protein localized to the nuclear fraction, as did IκBβ and p65. By co-immunoprecipitation, MEOX2 bound to both p65 and IκBβ. Immunofluorescence demonstrated that MEOX2 colocalizes in the nucleus with both p65 and IκBβ and that this colocalization requires the MEOX2 homeodomain and N-terminal domain. Finally, promoter assays revealed that MEOX2 expression has a biphasic effect on NF-κB-dependent promoters. At low levels, MEOX2 stimulates NF-κB activity, whereas at high levels, it represses, effects that also depend upon the homeodomain and the N-terminal domain. Conclusion Our results represent the first report of an interaction between a homeobox protein and IκBβ and suggest that MEOX2 modulates the activity of the RelA complex through direct interaction with its components. These observations implicate MEOX2 as a potentially important regulatory gene inhibiting not only the angiogenic response of ECs to proangiogenic factors, but also their response to chronic inflammatory stimulation that normally activates NF-κB, suggesting MEOX2 as a possible molecular target for the therapy of angiogenesis-dependent diseases such as cancer.

AB - Aims Tumours secrete proangiogenic factors to induce the ingrowth of blood vessels, the end targets of which are vascular endothelial cells (ECs). The MEOX2 homeoprotein inhibits nuclear factor-κB (NF-κB) signalling and EC activation in response to serum and proangiogenic factors. We hypothesize that MEOX2 interacts with components of this pathway in vascular ECs to modulate NF-κB activity and EC activation and that these interactions depend upon specific domains within the MEOX2 protein. Methods and results To test our hypothesis, we transduced ECs with MEOX2 expression constructs. MEOX2 protein localized to the nuclear fraction, as did IκBβ and p65. By co-immunoprecipitation, MEOX2 bound to both p65 and IκBβ. Immunofluorescence demonstrated that MEOX2 colocalizes in the nucleus with both p65 and IκBβ and that this colocalization requires the MEOX2 homeodomain and N-terminal domain. Finally, promoter assays revealed that MEOX2 expression has a biphasic effect on NF-κB-dependent promoters. At low levels, MEOX2 stimulates NF-κB activity, whereas at high levels, it represses, effects that also depend upon the homeodomain and the N-terminal domain. Conclusion Our results represent the first report of an interaction between a homeobox protein and IκBβ and suggest that MEOX2 modulates the activity of the RelA complex through direct interaction with its components. These observations implicate MEOX2 as a potentially important regulatory gene inhibiting not only the angiogenic response of ECs to proangiogenic factors, but also their response to chronic inflammatory stimulation that normally activates NF-κB, suggesting MEOX2 as a possible molecular target for the therapy of angiogenesis-dependent diseases such as cancer.

KW - Angiogenesis

KW - Homeodomain protein

KW - Nuclear factor-κB

KW - Transcriptional regulation

KW - Vascular endothelial cell

UR - http://www.scopus.com/inward/record.url?scp=77955871524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955871524&partnerID=8YFLogxK

U2 - 10.1093/cvr/cvq117

DO - 10.1093/cvr/cvq117

M3 - Article

VL - 87

SP - 723

EP - 731

JO - Cardiovascular Research

JF - Cardiovascular Research

SN - 0008-6363

IS - 4

ER -